// App-Quantinova.ai

4046 : The role of TFPI2 and FGF2 in asbestos-induced mesothelial to fibroblastic transition

Researchers

Presenter

  • Joyce K. Thompson

Principal Investigators

  • Jill Miller

  • Maximilian B. MacPherson

  • Arti Shukla

Medical Centers

  • University of Vermont, Burlington, VT

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mesothelioma

  • Solid malignancies

Biomarkers

  • Basic fibroblast growth factor

  • Interleukin 1

Drug/Treatment

  • Interleukin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A